A Zwitterionic Salt-Cocrystal: In-Vitro Insights from Niraparib Tosylate, an Anti-Cancer Drug

CrystEngComm, 2024, Accepted Manuscript DOI: 10.1039/D4CE00114A, PaperRamesh Reddy Mudda, Ramesh Devarapalli, Arijit Das, Pullareddy Lakkireddy, Chilla Malla Reddy, Ramanaiah Chennuru Niraparib is an anti-cancer drug marketed as a tosylate monohydrate salt (brand name ZEJULA). Although it was approved by the USFDA and the European Union in 2017, niraparib tosylate is... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - CrystEngComm latest articles - Category: Chemistry Authors: Source Type: research